Home / Feed aggregator / Sources / Yahoo! News Search Results for chronic constipation
chronic constipation - Yahoo! News Search Results
Updated: 19 hours 2 min ago
Sucampo Gains as Bowel Drug Meets Study Goal: Washington Mover
Sucampo Pharmaceuticals Inc. surged 42 percent over two days after reporting that its experimental medicine for opioid-induced bowel dysfunction met goals in a late-stage clinical trial.
Categories: Chronic Constipation News
Sucampo Gains as Bowel Drug Meets Study Goal: Washington Mover
Sucampo Pharmaceuticals Inc. surged for a second day after reporting that its experimental medicine for opioid-induced bowel dysfunction met goals in a late-stage clinical trial.
Categories: Chronic Constipation News
Press Release
Acorda Therapeutics Inc. Posted on:03 Feb 12 Acorda Therapeutics, Inc. (Nasdaq: ACOR ) presented data showing that treatment with dalfampridine improved motor function in a preclinical model of stroke, with treatment initiated at least four weeks following the ischemic event.
Categories: Chronic Constipation News
Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke
Acorda Therapeutics, Inc. presented data showing that treatment with dalfampridine improved motor function in a preclinical model of stroke, with treatment initiated at least four weeks following the ischemic event.
Categories: Chronic Constipation News
Gazette.Net: Constipation drug offers more potential for Bethesdas Sucampo
After a successful phase 3 clinical trial, Sucampo Pharmaceuticals of Bethesda is ready to apply for U.S. regulatory approval to market its constipation drug to people who have bowel dysfunction from taking morphine and codeine for chronic, non-cancer pain.
Categories: Chronic Constipation News
Ridiculous Pop Culture Conspiracy Theories
(Photos: Pacific Coast News, Getty Images, Flynet Picutres) Simply by being in the public eye, celebrities open themselves up to constant speculation and hearsay, and somehow the most absurd rumors take on a life of their own and become full-blown conspiracy theories. These urban legends are too far-out even for tabloids and their "sources" to report with any semblance of credibility, but enough ...
Categories: Chronic Constipation News
Sucampo Pharma's Lubiprostone Meets Key Goal In Phase III Trial For OBD - Update
Sucampo Pharmaceuticals Inc. (SCMP) and Takeda Pharmaceuticals U.S.A., Inc. announced Thursday that their drug lubiprostone, marketed under the trade name Amitiza, met the primary endpoint in a late-stage clinical trial for opioid-induced bowel dysfunction, or OBD.
Categories: Chronic Constipation News
Sucampo Pharma's Laxative Meets Key Goal In Phase III Trial For OBD - Update
Sucampo Pharmaceuticals Inc. (SCMP) and Takeda Pharmaceuticals U.S.A., Inc. announced Thursday that their drug lubiprostone, marketed under the trade name Amitiza, met the primary endpoint in a late-stage clinical trial for opioid-induced bowel dysfunction, or OBD.
Categories: Chronic Constipation News
Press Release
Sucampo Pharmaceuticals Inc. Posted on:02 Feb 12 Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial for the treatment of opioid-induced bowel dysfunction (OBD) in patients with chronic, non-cancer pain, excluding those taking methadone.
Categories: Chronic Constipation News
Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid-Induced Bowel Dysfunction (OBD)
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial fo
Categories: Chronic Constipation News
AstraZeneca PLC - Final Results - Part 3 of 3
Development Pipeline as at 31 December 2011 Line Extensions Compound Mechanism Area Under Investigation Phase Date Commenced Phase Estimated Filing US EU Japan Emerging Cardiovascular Axanum proton pump ...
Categories: Chronic Constipation News
Dealing With Death: Mistakes We All Make - Research Summary
DEATH & DYING: Several physical and emotional changes occur as death approaches, including: excessive sleepiness and weakness while overall energy declines; breathing changes; visual and hearing changes, such as seeing people or scenes others d ...
Categories: Chronic Constipation News
Minister Madzorera on typhoid outbreak
TYPHOID is systemic bacterial disease that is characterised by insidious onset of sustained fever, headache, malaise, anorexia, a relative bradycardia, splenomegaly rose spots on the trunk, a non productive cough in the early stages of the illness and constipation of diarrhoea in adults.
Categories: Chronic Constipation News
Press Release
AMAG Pharmaceuticals Inc. Posted on:30 Jan 12 AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the completion of patient enrollment in the second of the company’s two phase III studies that comprise its global registrational program for Feraheme ® (ferumoxytol) in patients with iron-deficiency anemia (IDA) who are not candidates for oral iron, regardless of the underlying cause.
Categories: Chronic Constipation News
AMAG Pharmaceuticals Announces Completion of Enrollment in its Phase III Program Evaluating Feraheme for a Broader ...
AMAG Pharmaceuticals, Inc. today announced the completion of patient enrollment in the second of the company’s two phase III studies that comprise its global registrational program for Feraheme® in patients with iron-deficiency anemia who are not candidates for oral iron, regardless of the underlying cause.
Categories: Chronic Constipation News
Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions
FLORHAM PARK, N.J., Jan. 25, 2012 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced results from two studies published online today in the journal Therapeutics ...
Categories: Chronic Constipation News
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
PALATINE, IL-- - Acura Pharmaceuticals, Inc. , a specialty pharmaceutical company, announced today that it has been informed by Pfizer, Inc. that OXECTA® Tablets CII is now commercially available. OXECTA, ...
Categories: Chronic Constipation News
Think you're bloated by IBS? It could just be Small Intestinal Bacterial Overgrowth and it's easier to manage
For years Patrick Strudwick, left, was told he had IBS but he soon discovered he actually had SIBO which made him look pregnant.
Categories: Chronic Constipation News
Cubist Pharmaceuticals Reports 2011 Fourth Quarter and Full Year Financial Results
Cubist Pharmaceuticals, Inc. today announced results for the fourth quarter and year ended December 31, 2011. The Company will host a conference call and webcast today at 5:00 p.m.
Categories: Chronic Constipation News
